Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | CSF1R | P07333 | 1/20 | 0.36 |
| ▸ | MET | P08581 | 1/20 | 0.36 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7873514 | 0.82 | ESR2 (0.45) | KCNA3 | |
| SCHEMBL16720374 | 0.82 | CNR2 (0.51) | ACHECNR2CNR1 | |
| SCHEMBL2012945 | 0.82 | ACHE (0.39) | ACHENISCHRAB9AMAP4K4PIM1 | |
| SCHEMBL1045097 | 0.82 | AKR1C3 (0.44) | ACHEMAOBADORA1ADORA2ARAB9A | |
| SCHEMBL695298 | 0.80 | ESR2 (0.44) | ACHERAB9ANPC1HPGDTSHR | |
| SCHEMBL8093287 | 0.80 | CYP1A1 (0.44) | ACHEMAOBRAB9ACNR2NPC1 | |
| SCHEMBL3536486 | 0.80 | CYP1A1 (0.44) | ACHENISCHMAOBADORA1ADORA2A | |
| SCHEMBL29068276 | 0.80 | CLK4 (0.44) | MAOBLRRK2MAP4K4CLK4IDO1 | |
| SCHEMBL695042 | 0.78 | RAPGEF4 (0.41) | ADORA1ADORA2AHPGDSMN1; SMN2IDO1 | |
| SCHEMBL1804627 | 0.78 | AKR1C3 (0.36) | ACHEMAOBADORA1ADORA2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118251380-A | Spiro- (indan-fluorene) compounds and their use in organic electronic devices | 多蒂肯独家合成控股公司 | 2024-06-25 | — | — | CN | disclosed |
| US-20240122065-A1 | METAL PATTERNING MATERIAL, AMINE COMPOUND, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | TOSOH CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-4342883-A1 | PHOTOELECTRIC CONVERSION ELEMENT MATERIAL FOR IMAGING ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT FOR IMAGING ELEMENT | Tosoh Corporation (JP) | 2024-03-27 | — | — | EP | disclosed |
| CN-117440940-A | Material for photoelectric conversion element for image pickup element and photoelectric conversion element for image pickup element | 东曹株式会社 | 2024-01-23 | — | — | CN | disclosed |
| CN-110997648-B | Condensed ring compound | 东曹株式会社 | 2023-12-19 | — | — | CN | disclosed |
| CN-117044428-A | Lateral current suppressing material, carbazole compound, hole injection layer, and organic electroluminescent element | 东曹株式会社 | 2023-11-10 | — | — | CN | disclosed |
| EP-3621946-B1 | INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2023-09-06 | — | — | EP | disclosed |
| CN-110740986-B | Indane derivatives and their use in organic electronic devices | 多蒂肯独家合成控股公司 | 2023-08-25 | — | — | CN | disclosed |
| EP-4198163-A1 | METAL PATTERNING MATERIAL, AMINE COMPOUND, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | Tosoh Corporation (JP) | 2023-06-21 | — | — | EP | disclosed |
| CN-116157382-A | Material for metal patterning, amine compound, electronic device, and method for forming metal pattern | 东曹株式会社 | 2023-05-23 | — | — | CN | disclosed |
| EP-3401305-A1 | INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2018-11-14 | — | — | EP | disclosed |
| US-9698352-B2 | Amine compound and use thereof | TOSOH CORPORATION (JP) | 2017-07-04 | — | — | US | disclosed |
| EP-2772483-B1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | TOSOH CORP (JP) | 2017-03-29 | — | — | EP | disclosed |
| EP-2902391-B1 | NOVEL AMINE COMPOUND AND USE THEREOF | TOSOH CORP (JP) | 2017-03-08 | — | — | EP | disclosed |
| US-9172045-B2 | 4-aminocarbazole compound and use thereof | TOSOH CORPORATION (JP) | 2015-10-27 | — | — | US | disclosed |
| US-20150243901-A1 | NOVEL AMINE COMPOUND AND USE THEREOF | TOSOH CORPORATION (JP) | 2015-08-27 | — | — | US | disclosed |
| EP-2902391-A1 | NOVEL AMINE COMPOUND AND USE THEREOF | Tosoh Corporation (JP) | 2015-08-05 | — | — | EP | disclosed |
| US-20140296519-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF | TOSOH CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| EP-2772483-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | Tosoh Corporation (JP) | 2014-09-03 | — | — | EP | disclosed |
| US-20070213374-A1 | Malonamide Derivatives | MERCK PATENT GMBH (DE) | 2007-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150243901-A1 | NOVEL AMINE COMPOUND AND USE THEREOF | DRD1, MLLT1, DRD4 | ACHE 3088/4885NISCH 2891/4885MAOB 1439/4885 |
| US-20070213374-A1 | Malonamide Derivatives | RAF1, BRAF, ARAF | ACHE 4071/4885NISCH 2412/4885MAOB 383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.